Recent Quotes

Eloxx Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing novel ribonucleic acid (RNA)-modulating drug candidates that are formulated to treat rare and ultra-rare premature stop codon diseases. The ELX-02, the company's lead investigational drug product candidate, is a small molecule designed to restore the production of full-length functional proteins. The ELX-02, is in the early stages of clinical development for systemic administration for cystic fibrosis and cystinosis.

Earnings

Q2 2021		Est.		Actual		Surprise
EPS		(EXPECTED)2021-08-05
REV		(EXPECTED)2021-08-05

Q1 2021		Est.		Actual		Surprise
EPS		-0.160		-0.220		-0.0600
REV				0

Analyst Ratings

Date	Analyst Firm	Analyst Name	Action	Rating	Action Price	Prior Price	Target

Related Companies

Ticker	Company	Price	Change	Chg %		Mkt Cap
ELOX	Eloxx Pharmaceuticals	1.37	-0.09	-6.16%		118.1M

Eloxx Pharmaceuticals Frequently Asked Questions

How do I buy Eloxx Pharmaceuticals (ELOX) stock?

You can purchase shares of Eloxx Pharmaceuticals (NASDAQ: ELOX) through any online brokerage.

View our list of the best stock brokerages.

Who are Eloxx Pharmaceuticals's (ELOX) competitors?

Other companies in Eloxx Pharmaceuticals’s space includes: Graybug Vision (NASDAQ:GRAY), Cocrystal Pharma (NASDAQ:COCP), SCYNEXIS (NASDAQ:SCYX), Lipocine (NASDAQ:LPCN) and Qilian Intl Hldg Gr (NASDAQ:QLI).

What is the target price for Eloxx Pharmaceuticals (ELOX) stock?

The latest price target for Eloxx Pharmaceuticals (NASDAQ: ELOX) was reported by Mizuho on June 30, 2021. The analyst firm set a price target for 3.10 expecting ELOX to rise to within 12 months (a possible 126.28% upside). 2 analyst firms have reported ratings in the last year.

Current Stock Price for Eloxx Pharmaceuticals (ELOX)?

The stock price for Eloxx Pharmaceuticals (NASDAQ: ELOX) is $1.37 last updated Fri Jul 23 2021 20:00:03 GMT+0000 (Coordinated Universal Time).

Does Eloxx Pharmaceuticals (ELOX) pay a dividend?

There are no upcoming dividends for Eloxx Pharmaceuticals.

When is Eloxx Pharmaceuticals (NASDAQ:ELOX) reporting earnings?

Eloxx Pharmaceuticals’s Q2 earnings are confirmed for after-market on August 5, 2021.

Is Eloxx Pharmaceuticals (ELOX) going to split?

There is no upcoming split for Eloxx Pharmaceuticals.

What sector and industry does Eloxx Pharmaceuticals (ELOX) operate in?

Eloxx Pharmaceuticals is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the NASDAQ.